Klimek Ludger, Bachert Claus, Pfaar Oliver, Becker Sven, Bieber Thomas, Brehler Randolph, Buhl Roland, Casper Ingrid, Chaker Adam, Czech Wolfgang, Fischer Jörg, Fuchs Thomas, Gerstlauer Michael, Hörmann Karl, Jakob Thilo, Jung Kirsten, Kopp Matthias V, Mahler Vera, Merk Hans, Mülleneisen Norbert, Nemat Katja, Rabe Uta, Ring Johannes, Saloga Joachim, Schlenter Wolfgang, Schmidt-Weber Carsten, Seyfarth Holger, Sperl Annette, Spindler Thomas, Staubach Petra, Strieth Sebastian, Treudler Regina, Vogelberg Christian, Wallrafen Andrea, Wehrmann Wolfgang, Wrede Holger, Zuberbier Torsten, Bedbrook Anna, Canonica Giorgio W, Cardona Victoria, Casale Thomas B, Czarlewski Wienczylawa, Fokkens Wytske J, Hamelmann Eckard, Jutel Marek, Larenas-Linnemann Désirée, Mullol Joaquim, Papadopoulos Nikolaos G, Toppila-Salmi Sanna, Werfel Thomas, Bousquet Jean
Center of Rhinology and Allergology, Wiesbaden, Germany.
Upper Airways Research Laboratory and Department of Oto-Rhino-Laryngology, Ghent University and Ghent, University Hospital, Ghent, Belgium, Division of ENT Diseases, CLINTEC, Karolinska Institute, University of Stockholm, Stockholm, Sweden.
Allergol Select. 2019 Dec 30;3(1):22-50. doi: 10.5414/ALX02120E. eCollection 2019.
The number of patients affected by allergies is increasing worldwide. The resulting allergic diseases are leading to significant costs for health care and social systems. Integrated care pathways are needed to enable comprehensive care within the national health systems. The ARIA (Allergic Rhinitis and its Impact on Asthma) initiative develops internationally applicable guidelines for allergic respiratory diseases.
ARIA serves to improve the care of patients with allergies and chronic respiratory diseases. In collaboration with other international initiatives, national associations and patient organizations in the field of allergies and respiratory diseases, real-life integrated care pathways have been developed for a digitally assisted, integrative, individualized treatment of allergic rhinitis (AR) with comorbid asthma. In the present work, these integrated care pathways have been adapted to the German situation and health system.
The present ICP (integrated care pathway) guideline covers key areas of the care of AR patients with and without asthma. It includes the views of patients and other healthcare providers.
A comprehensive ICP guideline can reflect real-life care better than traditional guideline models.
全球范围内受过敏影响的患者数量正在增加。由此产生的过敏性疾病给医疗保健和社会系统带来了巨大成本。需要综合护理途径以在国家卫生系统内实现全面护理。ARIA（变应性鼻炎及其对哮喘的影响）倡议制定了适用于国际的过敏性呼吸道疾病指南。
ARIA旨在改善对过敏和慢性呼吸道疾病患者的护理。与过敏和呼吸道疾病领域的其他国际倡议、国家协会及患者组织合作，已制定出针对合并哮喘的变应性鼻炎（AR）进行数字辅助、综合、个体化治疗的实际综合护理途径。在本研究中，这些综合护理途径已根据德国情况和卫生系统进行了调整。
当前的ICP（综合护理途径）指南涵盖了有或无哮喘的AR患者护理的关键领域。它纳入了患者和其他医疗服务提供者的观点。
全面的ICP指南比传统指南模式能更好地反映实际护理情况。
